2025-08-12 Drugs The SFDA Approves the Registration of Elrexfio for the Treatment of Adults with Multiple Myeloma
2025-08-10 Drugs SFDA Launches an Initiative to Enable Healthcare Professionals and Patients to Access Awareness Materials that Promote the Safe Use of Medications and Help Minimize Related Risks
2025-07-29 Drugs SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia
2025-07-28 Medical Devices SFDA Strengthens Global Standing Through Regulation of Medical Device Clinical Studies
2025-07-23 Drugs SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder
2025-07-20 Medical Devices SFDA Advances Healthcare Innovation Through Clinical Trials and Gene Therapy
